Intravenous sildenafil (Viagra®) and pulmonary vascular resistance in children with congenital heart disease

被引：0
|
作者：
Schulze-Neick, I [1 ]
Li, J [1 ]
Petros, A [1 ]
Redington, AN [1 ]
机构：
[1] Great Ormond St Hosp Children, Cardiothorac Unit, London WC1, England
来源：
EUROPEAN HEART JOURNAL | 2001年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [31] THE ROLE OF THE PULMONARY VASCULAR BED IN CONGENITAL HEART DISEASE
    DAMMANN, JF
    MULLER, WH
    PEDIATRICS, 1953, 12 (03) : 307 - 325
  • [32] PULMONARY VASCULAR RESISTANCE IN ACQUIRED HEART DISEASE
    CHARMS, BL
    BROFMAN, BL
    AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES, 1959, 79 (06): : 828 - 828
  • [33] Impact of Sildenafil Therapy on Pulmonary Arterial Hypertension in Adults with Congenital Heart Disease
    Lu, Xian-Ling
    Xiong, Chang-Ming
    Shan, Guang-Liang
    Zhu, Xian-Yang
    Wu, Bing-Xiang
    Wu, Guang-Hua
    Liu, Zhi-Hong
    Ni, Xin-Hai
    Cheng, Xian-Sheng
    Gu, Qing
    Zhao, Zhi-Hu
    Zhang, Duan-Zhen
    Li, Wei-Min
    Zhang, Cheng
    Tian, Hong-Yan
    Guo, Ya-Juan
    Guo, Tao
    Liu, Hong-Min
    Zhang, Wei-Jun
    Gu, Hong
    Huang, Shi-An
    Chen, Jian-Ying
    Wu, Wei-Feng
    Huang, Kai
    Li, Jian-Jun
    He, Jian-Guo
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (06) : 350 - 355
  • [34] The Treatment of Congenital Heart Disease Associated Pulmonary Arterial Hypertension (PAH) with Sildenafil
    Crackett, R. M.
    Foggo, B. A.
    Day, M. B.
    Small, T.
    Mackay, L. S.
    Fisher, A. J.
    Lordan, J. L.
    MacGowan, G.
    Corris, P. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [35] Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease - An indicator for pulmonary vascular disease?
    Berger, RMF
    Cromme-Dijkhuis, AH
    Hop, WCJ
    Kruit, MN
    Hess, J
    CHEST, 2002, 122 (02) : 549 - 557
  • [36] VALIDATION OF THE FLOW-THROUGH TECHNIQUE FOR COMPUTATION OF PULMONARY VASCULAR-RESISTANCE IN CHILDREN WITH CONGENITAL HEART-DISEASE AND PULMONARY-HYPERTENSION
    CAPDEROU, A
    DOUGUET, D
    LOSAY, J
    ZELTER, M
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A130 - A130
  • [37] Impact of Pulmonary Vascular Resistances in Heart Transplantation for Congenital Heart Disease
    Gazit, Avihu Z.
    Canter, Charles E.
    CURRENT CARDIOLOGY REVIEWS, 2011, 7 (02) : 59 - 66
  • [38] Sildenafil in the treatment of postoperative hypoxemia with high resistance in cyanotic congenital heart disease
    Zhou J.
    Lv Y.
    Hu Z.
    Qiu Z.
    Peng R.
    Xue Y.
    American Journal of Biochemistry and Biotechnology, 2017, 13 (03): : 140 - 147
  • [39] Elevated pre-transplant pulmonary vascular resistance is not associated with mortality in children without congenital heart disease: A multicenter study
    Richmond, Marc E.
    Law, Yuk M.
    Das, Bibhuti B.
    Everitt, Melanie D.
    Kukreja, Manisha
    Naftel, David C.
    Kemna, Mariska S.
    Henderson, Heather T.
    Beddows, Kimberly
    Fricker, F. Jay
    Mahle, William T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (03): : 448 - 456
  • [40] Low Nasal Nitric Oxide as a Biomarker for Increased Pulmonary Vascular Resistance in Congenital Heart Disease
    Vithana, Rukmalee
    Adams, Phillip
    Zahid, Maliha
    Leatherbury, Linda
    West, Shawn
    Kreutzer, Jacqueline
    Lo, Cecilia
    CIRCULATION, 2017, 136
12345